Climb Bio, Inc.

CLYM · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$74-$35-$45-$47
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$6$13$7$4
Change in WC$2$4$0-$4
Other Non-Cash$51-$2$1$12
Operating Cash Flow-$16-$21-$37-$36
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$132-$58-$88-$115
Inv. Sales/Matur.$21$127$122$0
Other Inv. Act.-$10$0$0$0
Investing Cash Flow-$121$69$34-$115
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$120$1$0$83
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$11$0$0$94
Financing Cash Flow$131$1$0$177
Forex Effect$0$0-$0$0
Net Chg. in Cash-$6$50-$3$26
Supplemental Information
Beg. Cash$93$44$47$20
End Cash$87$93$44$47
Free Cash Flow-$16-$21-$37-$36